Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
Public ClinicalTrials.gov record NCT02117934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Study identification
- NCT ID
- NCT02117934
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Dynavax Technologies Corporation
- Industry
- Enrollment
- 8,374 participants
Conditions and interventions
Conditions
Interventions
- HEPLISAV Biological
- Engerix-B Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Sep 30, 2015
- Completion
- Sep 30, 2015
- Last update posted
- Mar 19, 2019
2014 – 2015
United States locations
- U.S. sites
- 40
- U.S. states
- 17
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Advantage, Inc. | Birmingham | Alabama | 35211 | — |
| Clinical Research Advantage, Inc. | Chandler | Arizona | 85224 | — |
| Radiant Research | Chandler | Arizona | 85224 | — |
| Clinical Research Advantage, Inc. | Glendale | Arizona | 85306 | — |
| Clinical Research Advantage, Inc. | Mesa | Arizona | 85206 | — |
| Clinical Research Advantage, Inc. | Mesa | Arizona | 85213 | — |
| Clinical Research Advantage, Inc. | Phoenix | Arizona | 85018 | — |
| Clinical Research Advantage, Inc. | Phoenix | Arizona | 85020 | — |
| Clinical Research Advantage, Inc. | Phoenix | Arizona | 85050 | — |
| Radiant Research | Scottsdale | Arizona | 85251 | — |
| Clinical Research Advantage, Inc. | Tempe | Arizona | 85283 | — |
| Radiant Research | Tucson | Arizona | 85712 | — |
| Clinical Research Advantage, Inc. | Tucson | Arizona | 85741 | — |
| Radiant Research | Santa Rosa | California | 95405 | — |
| Clinical Research Advantage, Inc. | Vista | California | 92083 | — |
| Clinical Research Advantage, Inc. | Centennial | Colorado | 80112 | — |
| Clinical Research Advantage, Inc. | Colorado Springs | Colorado | 80922 | — |
| Radiant Research | Denver | Colorado | 80239 | — |
| Radiant Research | Pinellas Park | Florida | 33781 | — |
| Radiant Research | Atlanta | Georgia | 30342 | — |
| Radiant Research | Chicago | Illinois | 60654 | — |
| Clinical Research Advantage, Inc | Evansville | Indiana | 47725 | — |
| Clinical Research Advantage, Inc. | Council Bluffs | Iowa | 51503 | — |
| Radiant Research | Edina | Minnesota | 55435 | — |
| Radiant Research | St Louis | Missouri | 83141 | — |
| Clinical Research Advantage, Inc. | Elkhorn | Nebraska | 68022 | — |
| Clinical Research Advantage, Inc. | Fremont | Nebraska | 68025 | — |
| Clinical Research Advantage, Inc. | Omaha | Nebraska | 68124 | — |
| Clinical Research Advantage, Inc. | Henderson | Nevada | 89052 | — |
| Clinical Research Advantage, Inc. | Las Vegas | Nevada | 89128 | — |
| Radiant Research | Akron | Ohio | 44311 | — |
| Radiant Research | Cincinnati | Ohio | 45249 | — |
| Radiant Research | Columbus | Ohio | 43212 | — |
| Clinical Research Advantage, Inc. | Anderson | South Carolina | 29621 | — |
| Radiant Research | Anderson | South Carolina | 29621 | — |
| Radiant Research | Greer | South Carolina | 29650 | — |
| Radiant Research | Dallas | Texas | 75231 | — |
| Clinical Research Advantage, Inc. | Plano | Texas | 75093 | — |
| Radiant Research | San Antonio | Texas | 78229 | — |
| Radiant Research | Murray | Utah | 84123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02117934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02117934 live on ClinicalTrials.gov.